healthcare

October 15, 2018

Hair is an aesthetic that forms a lasting impression on others. Lush, healthy tresses are highly desired by many, however, certain factors - ranging from genetics to environment - could easily affect the condition of one's hair and scalp.

To help nourish and enhance the redeeming qualities of healthy hair, Japanese brand Kaminomoto has been helping generations with its portfolio of special formulations. Established in 1908, the Japanese brand offers a rich legacy of hair care products formulated with a blend of ingredients derived from Japanese medicinal plants and natural extracts.

'In"...

Continue Reading >

October 15, 2018

(WAM) -- DV Global Link, the joint venture between Italian Exhibition Group and Dubai World Trade Centre, has signed a Memorandum of Understanding with ANFAO, the Italian Optical Goods Manufacturers’ Association, a Confindustria associate. The agreement initiates the establishment of a partnership, which will lead to the participation of ANFAO member companies at the Dubai Optical Show - Vision X (DOS – VX), the exhibition dedicated to the eyewear sector, scheduled to take place in Dubai from 13th to 15th November.

Thanks to the agreement between DV Global Link and ANFAO, Italian companies will have a prestigious platform at their"...

Continue Reading >

October 15, 2018

  • Data from key trials will aid in increasing scientific understanding of ESUS and CVT
  • RESPECT-ESUS is first randomised trial to investigate clinical profile of Pradaxa® vs ASA

(AETOS Wire) -- Boehringer Ingelheim today announced that primary results from two key trials, RE-SPECT ESUS® and RE-SPECT CVT®, will be presented at the upcoming World Stroke Congress in Montreal, Canada 17-20 October 2018. These primary analyses will contribute to the scientific community’s understanding of both disease states and the clinical profile of dabigatran etexilate (Pradaxa®).

"...

Continue Reading >

October 15, 2018

Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has announced its entry into the oncology market through a license and supply agreement with Russia’s leading biotechnology company, BIOCAD.

Julphar will be partnering with BIOCAD and Health Authorities to register three leading specialized products to the UAE, which are used to treat breast cancer, B-cell non-Hodgkin's lymphoma, chronic lymphocytic leukemia, colon cancer, lung cancer and glioblastoma.

Commenting on the announcement,"...

Continue Reading >

October 13, 2018

The 10th edition of UAE Cancer Congress opened in Dubai today (October 11), aiming to promote the most recent advances in cancer research while also highlighting the various scientific developments in the field.

Inaugurated by Sheikh Nahyan Mabarak Al Nahyan, UAE Cabinet Minister, Minister of Tolerance and president of the UAE Genetics Association, the event runs until October 13, and is organized by INDEX Conferences and Exhibitions in partnership with UAE Genetics Association, under the theme ‘Promoting Excellence in Oncology and Striking away Cancer’, at the InterContinental Festival City Hotel in Dubai.

During his keynote address, Sheikh Nahyan said, “UAE healthcare vision"...

Continue Reading >

October 11, 2018

Dubai Health Authority (DHA), an official supporter of Expo 2020 Dubai, said it will set up medical facilities at the Expo to ensure the health and safety of the event, which is likely to attract around 25 million visits from 180 countries.

The announcement was made following the signing of a memorandum of understanding (MoU) between the DHA and Expo 2020 Dubai today (October 10) in the presence of Reem Al Hashimy, UAE Minister of State for International Cooperation and director general Dubai Expo 2020 Bureau and Humaid Al Qutami, director general of DHA.

The DHA and Expo 2020 Dubai signed the MoU to launch the first emergency centre that will cater to patients during the construction phase."...

Continue Reading >

October 11, 2018

Jehad International Medical Clinic (JIMC), a specialised medical service provider in Dubai, has achieved accreditation by the Joint Commission International (JCI) for the third time. This accreditation is for the medical facility’s commitment to demonstrate compliance with the global organisation’s quality and patient safety standards.

JIMC is an advanced clinic for the treatment of hemorrhoids and other ano-rectal diseases without conventional surgery. The clinic offers expertise by the first surgeon in the UAE to offer infrared rays and laser treatments for hemorrhoids, thus the patient can go"...

Continue Reading >

October 11, 2018

Hallstar, a specialty chemical company headquartered in Chicago, has been awarded the 2018 ITEHPEC Innovation Silver Prize for its anti-blue light, anti-pollution, eco-designed active, BLUE Oléoactif®.

The ITEHPEC (Inovação e Tecnologia em Higiene Pessoal, Perfumaria, e Cosméticos) Innovation Award, created in 2005 by Brazil’s most important personal care association, recognizes suppliers that contribute to the Brazilian cosmetic industry through new ingredients or processes. Award winners were announced at in-cosmetics Latin America in Sao Paulo on September 18th.

BLUE"...

Continue Reading >

October 11, 2018

When a 40-year-old, Maryam, an Arab national was diagnosed with advanced stage breast cancer, she found herself in the hardest battle of her life. Maryam discovered her condition when she visited her doctor for a regular check-up. What came next, left her devastated. She was diagnosed with cancer, which dwelled in her for several months. To add to her woes, what came next was even more distressing. Her breast surgeon suggested a mastectomy - amputating the entire breast to treat the cancer. While the pain of cancer was not enough, the idea of having a mastectomy shattered the young woman. However, her breast surgeon told her about the possibilities of breast reconstruction surgery at CosmeSurge, which not only would complete"...

Continue Reading >

October 10, 2018

FOR MEDICAL AND TRADE MEDIA ONLY

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) seeking approval for esketamine nasal spray, a glutamate receptor modulator, for treatment-resistant depression (TRD) in adults with Major Depressive Disorder (MDD) who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.

Esketamine nasal spray is an investigational product for the"...

Continue Reading >